Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 17,36117,380 of 20,252 grants

Completed TRAINING, INDIVIDUAL
Molecular and cancer-related roles of ACLY exon 14
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2021 – 2025

Project Summary The goal of this proposal is to understand the molecular role of alternative splicing and phosphorylation of ATP- citrate lyase (ACLY) exon 14 and how these events...

$476.9K
USD
Completed NON-SBIR/STTR RPGS
SPHERE (Survivorship Plan Health Record) Implementation Trial
NATIONAL CANCER INSTITUTE Indiana University Indianapolis United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT The Institute of Medicine recommends that each cancer patient receive a survivorship care plan that summarizes information important to the individual’s lo...

$6.15M
USD
Completed TRAINING, INDIVIDUAL
Role of IRF2BP2 in Tumor Immune Evasion
NATIONAL CANCER INSTITUTE Case Western Reserve University United States 2021 – 2025

PROJECT ABSTRACT Understanding the tumor microenvironment (TME) and the prognostic relevance of the cells contributing to it is vital for developing novel treatments for medullobla...

$526.9K
USD
Completed TRAINING, INDIVIDUAL
Clinical trial data analysis to design novel treatment regimens in oncology
NATIONAL CANCER INSTITUTE Harvard Medical School United States 2021 – 2024

Project summary Despite the recent development of new treatment modalities in oncology, the overall approval rate for cancer therapeutics is low: only 3% of drugs tested in a phase...

$526.9K
USD
Completed NON-SBIR/STTR RPGS
Novel Mechanistic Approaches in Prevention, Treatment and Non-Invasive Assessment of Radiation Cystitis in Mice
NATIONAL CANCER INSTITUTE University of Pittsburgh At Pittsburgh United States 2021 – 2025

ABSTRACT Pelvic organ tumors in men and women are projected to account for 40% and 18%, respectively, of new cancers diagnosed, and 31% and 26%, respectively, of cancer related dea...

$4.41M
USD
Completed NON-SBIR/STTR RPGS
Investigation of novel signaling protein in 3D and in vivo PDAC models using second generation Ref-1 inhibitors
NATIONAL CANCER INSTITUTE Indiana University Indianapolis United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Five-year survival rate of pancreatic ductal adenocarcinoma (PDAC) still remains at a dismal 10%. This poor outcome is attributed to PDAC’s complex tumor m...

$4.25M
USD
Completed NON-SBIR/STTR RPGS
Mechanistic understanding of the lifecycle of a circulating hybrid cell
NATIONAL CANCER INSTITUTE Oregon Health & Science University United States 2021 – 2026

Metastatic disease accounts for >90% of cancer-related deaths worldwide, yet this phase of tumor progression is the least biologically understood. The consequence of this lack o...

$6.24M
USD
Completed NON-SBIR/STTR RPGS
Lentiviral-Induced Swine Model of Spinal Cord Glioma
NATIONAL CANCER INSTITUTE Emory University United States 2021 – 2026

PROJECT SUMMARY High-grade Spinal Cord Glioma (SCG) is an orphan disease that results in significant morbidity and mortality, with no effective treatment options available. Despite...

$5.22M
USD
Completed NON-SBIR/STTR RPGS
The Effects of IQOS Use on Cigarette Smoking Behavior
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2021 – 2024

PROJECT SUMMARY Despite increased morbidity and mortality, 34 million adults in the United States smoke combustible cigarettes. Heat-not-burn (HNB) tobacco products are an emerging...

$4.5M
USD
Completed NON-SBIR/STTR RPGS
Prostate Cancer Vulnerabilities to BH3 Mimetic Drugs
NATIONAL CANCER INSTITUTE Beth Israel Deaconess Medical Center United States 2021 – 2026

The anti-apoptotic BCL2 family proteins (including BCL2, BCLXL, and MCL1) act by neutralizing BAX and BAK, and by inhibiting the BH3-only pro-apoptotic proteins that can activate B...

$3.92M
USD
Completed NON-SBIR/STTR RPGS
Determining the structural- and functional-level effects of diet-specific interventions on the gut microbiota of a diverse sample of Southern United States adults
NATIONAL CANCER INSTITUTE H. Lee Moffitt Cancer Ctr & Res Inst United States 2021 – 2026

Racial disparities in colorectal cancer (CRC) incidence persist for blacks and whites. Given the previous work of our team documenting racial differences in the gut microbiota of b...

$3.67M
USD
Completed NON-SBIR/STTR RPGS
Mechanistic understanding of the lifecycle of a circulating hybrid cell.
NATIONAL CANCER INSTITUTE Oregon Health & Science University United States 2021 – 2026

Project Summary Metastatic disease accounts for >90% of cancer-related deaths worldwide, yet this phase of tumor progression is the least biologically understood. The consequenc...

$141.9K
USD
Completed OTHER RESEARCH-RELATED
Ceramide NanoLiposomes as a novel therapeutic for prostate cancer
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2021 – 2025

Project Summary/Abstract Prostate cancer (PCa) is the second most incident cancer in men worldwide and despite vast amounts of research, treatment of this disease remains elusive....

$816.4K
USD
Completed NON-SBIR/STTR RPGS
Targeting colorectal cancer stem cells with ALDH1B1 antagonists
NATIONAL CANCER INSTITUTE Stanford University United States 2021 – 2026

Colorectal cancer is the third most common malignancy in the world, with approximately 1.4 million new cases and 700,000 deaths each year. Global incidence rates are expected to es...

$4.32M
USD
Completed TRAINING, INDIVIDUAL
Role of a Two-Factor Genetic Circuit Regulating Stemness in Colorectal Cancer
NATIONAL CANCER INSTITUTE Harvard Medical School United States 2021 – 2025

Project Summary Colorectal cancer (CRC) is the third leading cause of cancer death worldwide. Cancer stem cells (CSCs) in the colon are the source of tumor initiation, proliferatio...

$526.9K
USD
Completed NON-SBIR/STTR RPGS
Development of a novel biodegradable inorganic nanoparticle therapeutic for cancer
NATIONAL CANCER INSTITUTE University of Georgia United States 2021 – 2025

Abstract Bladder cancer is the sixth most prevalent cancer malignancy. More than 80,000 new cases are diagnosed in the USA each year, among which 75% are non-muscle-invasive bladde...

$5.26M
USD
Completed TRAINING, INDIVIDUAL
Defining protein synthesis demands and specificities in multiple myeloma
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2021 – 2024

PROJECT SUMMARY Multiple Myeloma (MM) is an incurable cancer of differentiated B lymphocytes (or “plasma cells”) which generally presents late in life and has a median life expecta...

$526.9K
USD
Completed OTHER RESEARCH-RELATED
Improving Family Cancer History Collection using Social Network, Human Centered Design, and Implementation Science Approaches
NATIONAL CANCER INSTITUTE Medical University of South Carolina United States 2021 – 2025

PROJECT SUMMARY The research strategy and training plan included in this F99/K00 proposal will enhance the career development and research independence of Caitlin G. Allen, MPH. Th...

$1.01M
USD
Completed TRAINING, INDIVIDUAL
Expanding the Druggable Human Genome
NATIONAL CANCER INSTITUTE Iowa State University United States 2021 – 2026

PROJECT SUMMARY: Most small molecule drugs elicit their effects by modulating protein function, despite the fact that only a small portion of the genome is translated (~1-2%). Furt...

$407.5K
USD
Completed NON-SBIR/STTR RPGS
Endometrial epithelial stem cells and cancer
NATIONAL CANCER INSTITUTE Cornell University United States 2021 – 2026

Uterine cancer is the 4th most frequent malignancy and the 6th cause of cancer-related deaths in women in the US. While the incidence and mortality rates of some cancers, such as l...

$4.12M
USD